About me
May Mo is an Executive Director of Biostatistics and the Head of Design and Innovation (D&I) group within the Center of Design and Analysis (CfDA) at Amgen. In her role, she leads an internal statistical consulting team with Directors of Statistical Innovation and Modeling and Simulation statisticians to provide strategic consultation and analytic expertise to product teams and promote innovative clinical trial designs and enable simulation-guided development program planning. May has many years of drug and device development experience across disease areas including oncology, hematology oncology, inflammation, neurology and nephrology.
